IRCT20230717058817N1
Recruiting
Phase 1
Evaluating the effect of oral Propranolol in pereventing the progression of retinopathy of prematurity
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- retinopathy of prematurity.
- Sponsor
- Ardabil University of Medical Sciences
- Enrollment
- 66
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Infants , with a gestational age of less than 32 weeks or a birth weight below 1500 grams,
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
effect of Propranolol in Traumatic Brain Injury (TBI)IRCT20130310012776N4Shiraz University of Medical Sciences110
Recruiting
Phase 3
Investigating the efficacy of oral propranolol in prevention of severe Retinopathy of PrematurityIRCT20101018004961N12Kermanshah University of Medical Sciences50
Completed
Phase 2
Oral propranolol and retinopathy of prematurityIRCT20100512003915N21Tabriz University of Medical Sciences72
Not yet recruiting
Phase 2
Propranolol and hemodynamics and sedatioIRCT20210614051574N1Esfahan University of Medical Sciences72
Completed
Not Applicable
Clinical study of oral propranolol treatment for pediatric hemangioma and lymphangiomapediatric hemangioma and lymphangiomaJPRN-UMIN000004453Gifu University Graduate School of Medicine50